PB1929: EFFICACY AND SAFETY OF ACALABRUTINIB IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: AN OPEN-LABEL, MULTICENTER PHASE 1/2 TRIAL

por Yang, Shenmiao, Huang, Haiwen, Zhou, Keshu, Zhao, Xielan, Han#, Yan-Qiu, LI, Lindong, Butturini, Anna, Wang, Yiqiu, Liu, Xiaofeng, Lai, Peiqiong, LI, Jianyong
Publicado 2023